Sanuwave Completes Modular PMA For Diabetic Foot Ulcer Treatment
This article was originally published in The Gray Sheet
Executive Summary
Sanuwave Health completed a modular PMA application for its dermaPACE diabetic foot ulcer treatment with the submission of pivotal trial data, announced July 6.